semaglutide canada patent expiry Novo's Ozempic Expires Jan. 4 in Canada, But Generics Not Imminent Looming GLP-1 drug patent expirations

Health Miracle Promises : From curing goiter to weight loss without diet or exercise, these benefits are exaggerated and unsupported by legitimate science

Clinical trials demonstrate waist circumference reductions of approximately 9-10 cm with semaglutide and 14-18 cm with tirzepatide over treatment periods of 60-72 weeks

When morning application makes sense Despite the advantages of evening application, morning use has legitimate benefits for certain goals and certain routines

Understanding why dizziness may occur and how to manage it effectively allows most patients to continue benefiting from improved glycaemic control

doi: 10.3390/ijms23010370 11